Oral Vaccine Market –By Vaccine Type (Live vaccine, Inactive Vaccine, Recombinant Vaccine, Others) By Application (Polio, Rabies, Tuberculosis, Influenza, Respiratory infections, HIV, Others) By End User (Hospitals, Government vaccination programs, Research institutes, others) By Region (North America, Europe, Asia Pacific, Middle East & Africa, RoW) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: Aug 2020
No. of Pages: 180
Status: Published
Report Code: ARI100860
Summary
Oral vaccination is the most challenging vaccination method owing to the administration route. On the other hand, oral vaccination has socio-economic benefits and provides the possibility of stimulating both humoral and cellular immune responses at systemic and mucosal sites. Regardless of the benefits of oral vaccination, only few numbers of oral vaccines are presently approved for human use. During the last decade, significant research regarding antigen-based oral vaccination methods have enhanced immunogenicity and induced desired immunological outcomes. Oral vaccination has taken immunization process to subsequent level. Majority of vaccines are given by parenteral route due to instability in gastric environment except for some vaccines the oral route is cost effective and feasible to combat non- mucosal transmitted infections. Oral vaccination has positive patient compliance than parenteral vaccines.
The increasing prevalence of chronic diseases like cancer and cancer-causing infections, the rising number of collaborations between market players and therefore the growing R&D interest in childhood diseases like growth hormone deficiency (GHD) should be the main drivers of market growth during the forecast period. Moreover, resistance issues with existing vaccines and various government initiatives to market vaccination are also expected to spice up market growth. Whereas, first pass metabolism issues with some drugs is that the major restraining factor for the market growth. However, biologic drugs like therapeutic proteins or oral vaccines are often not widely available, or very affordable for those in lower income countries, something which the report suggest may limit market growth.
The major prominent kay players operating in the global oral vaccines market are GlaxoSmithKline Plc., Merck & Co. Inc., Aventis (Sanofi S.A.), Swiss Serum and Vaccine Institute Berne, QUÍMICA SUIZA S.A., PaxVax Corporation, VALNEVA Canada Inc., Janssen Pharmaceuticals, Serum Institute of India Pvt. Ltd., and Shanghai BravoBio Co., Ltd.
Analyst Commentary
The stringency of regulations surrounding these biologics and regarding COVID-19 containment measures – including that current good manufacturing practice (CGMP) regulations and proposals state employees showing symptoms of COVID-19 shall be restricted from entering the production house premises of the corporate to stop contamination of drugs and active pharmaceutical ingredients (API). North America captured a prominent market share in 2016 due to the high purchasing power of the region’s population to afford costly vaccines and therefore the periodical mass immunization programs held by the government. However, Asia Pacific is predicted to witness a considerable CAGR on account of the rising incidence of HIV and influenza in developing countries.
Segmentation
Global Oral Vaccine Market has been segmented on the basis of Vaccine Type, Application, End User Industry, End User and Region. Based on Vaccine Type market is segmented into Live vaccine, Inactive Vaccine, Recombinant Vaccine and others. Based on Application market is segmented into Polio, Rabies, Tuberculosis, Influenza, Respiratory infections, HIV and others. Based on End User market is segmented into Hospitals, Government vaccination programs, Research institutes and others. Based on Region market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Rest of World.
Regional Analysis
North America will corner the most important share of the oral vaccine market and exhibit the maximum global oral vaccines market rate of growth due to increasing healthcare expenditure and the escalating prevalence of cardiovascular diseases (CVDs) which should drive demand for therapeutic proteins. According to the report, the US Centers for Medicare & Medicaid Services (CMS) estimate that health spending within the US will grow at a mean rate of 5.5 percent per annum between 2018 and 2027 to attain around $6 trillion by 2027. However, Asia Pacific is expected to witness a significant CAGR on account of the rising incidence of HIV and influenza in developing countries.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. DataComponent
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Oral Vaccine Market
Chapter 5. Global Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
5.1. Global Oral Vaccine Market Share, By Vaccine Type, 2015 - 2027(USD Million)
5.1.1. Live vaccine
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Inactive Vaccine
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Recombinant Vaccine
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Others
5.1.4.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
6.1. Global Oral Vaccine Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Polio, Rabies
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Tuberculosis
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Influenza
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Respiratory infections
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.5. HIV
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.6. Others
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Oral Vaccine Market Overview, By End User, 2015 - 2027(USD Million)
7.1. Global Oral Vaccine Market Share, By End User, 2015 - 2027 (USD Million)
7.1.1. Hospitals
7.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Government vaccination programs
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. Research Institutes
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Oral Vaccine Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Oral Vaccine Market Share, By Geography, 2015 - 2027(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2027(USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Oral Vaccine Market Overview, 2015 - 2027(USD Million)
9.1.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.2. North America Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
9.1.3. North America Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. North America Oral Vaccine Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.5. North America Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
9.1.5.1. U.S. Oral Vaccine Market Overview, 2015 - 2027(USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.5.1.2. U.S. Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Oral Vaccine Market Overview, 2015 - 2027(USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.5.2.2. Canada Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Oral Vaccine Market Overview, 2015 - 2027(USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.5.3.2. Mexico Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Oral Vaccine Market Overview, 2015 - 2027(USD Million)
10.1.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.2. Europe Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
10.1.3. Europe Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Europe Oral Vaccine Market Overview, By End User,2015 - 2027 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027(USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.1.2. Germany Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
10.1.5.1.3. Germany Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.2.2. France Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
10.1.5.2.3. France Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.3.2. UK Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
10.1.5.3.3. UK Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.4.2. Italy Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
10.1.5.4.3. Italy Oral Vaccine Market Overview, By Application2015 - 2027(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.5.2. Spain Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
10.1.5.5.3. Spain Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
10.1.5.6.3. Rest of Europe Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Asia Pacific Oral Vaccine Market Overview, 2015 - 2027(USD Million)
11.1.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.2. Asia Pacific Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Oral Vaccine Market Overview, By End User,2015 - 2027 (USD Million)
11.1.5. Asia Pacific Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.1.2. India Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
11.1.5.1.3. India Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
11.1.5.2.3. China Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.3.2. Japan Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.5.2. Rest of Asia Pacific Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
12.1. Middle East & Africa Oral Vaccine Market Overview, 2015 - 2027(USD Million)
12.1.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.2. Middle East & Africa Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Oral Vaccine Market Overview, By End User,2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.5.1.2. GCC Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
12.1.5.1.3. GCC Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.5.2.2. South Africa Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
12.1.5.2.3. South Africa Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.5.3.2. Rest of Middle East & Africa Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
12.1.5.3.3. Rest of Middle East & Africa Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Oral Vaccine Market Overview, By Countries, 2015 - 2027(USD Million)
13.1. South America Oral Vaccine Market Overview, 2015 - 2027(USD Million)
13.1.1. Market Size and projections, 2015 - 2027(USD Million)
13.1.2. South America Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027 (USD Million)
13.1.3. South America Oral Vaccine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.4. South America Oral Vaccine Market Overview, By End User,2015 - 2027 (USD Million)
13.1.5. South America Oral Vaccine Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2027(USD Million)
13.1.6.2. Brazil Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
13.1.6.3. Brazil Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2027(USD Million)
13.1.7.2. Argentina Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
13.1.7.3. Argentina Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2027
13.1.8.2. Rest of South America Oral Vaccine Market Overview, By Vaccine Type, 2015 - 2027(USD Million)
13.1.8.3. Rest of South America Oral Vaccine Market Overview, By Application, 2015 - 2027(USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Government vaccination programs
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. GlaxoSmithKline Plc
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Merck & Co. Inc
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. The Toro Company
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Aventis
15.5. Swiss Serum and Vaccine Institute Berne
15.6. PaxVax Corporation
15.7. VALNEVA Canada Inc
15.8. Janssen Pharmaceuticals
15.9. Others
Chapter 16. Oral Vaccine Market Cost Analysis
16.1. Oral Vaccine Key Raw Material Analysis
16.1.1. Key Raw Materials
16.1.2. Price Trend of Key Raw Materials
16.1.3. Key Suppliers of Raw Materials
16.1.4. Market Concentration Rate of Raw Materials
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Oral Vaccine Industrial Chain Analysis
17.2. Upstream Size Sourcing
17.3. Oral Vaccine Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Oral Vaccine Market share, By Vaccine Type, 2020 & 2027 (%)
10. Global Oral Vaccine Market share, by Live vaccine, By Vaccine Type, 2015 - 2027(USD Million)
11. Global Oral Vaccine Market share, by Inactive Vaccines, By Vaccine Type, 2015 - 2027 (USD Million)
12. Global Oral Vaccine Market share, by Recombinant Vaccine, By Vaccine Type, 2015 - 2027 (USD Million)
13. Global Oral Vaccine Market share, by Others, By Vaccine Type, 2015 - 2027 (USD Million)
14. Global Oral Vaccine Market share, By Application, 2020 & 2027 (%)
15. Global Oral Vaccine Market share, by Polio, Rabies, By Application, 2015 - 2027(USD Million)
16. Global Oral Vaccine Market share, by Tuberculosis, By Application, 2015 - 2027(USD Million)
17. Global Oral Vaccine Market share, by Influenza, By Application, 2015 - 2027(USD Million)
18. Global Oral Vaccine Market share, by Respiratory infections, By Application, 2015 - 2027(USD Million)
19. Global Oral Vaccine Market share, by HIV, By Application, 2015 - 2027(USD Million)
20. Global Oral Vaccine Market share, by Others, By Application, 2015 - 2027(USD Million)
21. Global Oral Vaccine Market share, By End User, 2020 & 2027 (%)
22. Global Oral Vaccine Market share, by Hospitals, By End User, 2015 - 2027(USD Million)
23. Global Oral Vaccine Market share, by Government vaccination programs, By End User, 2015 - 2027 (USD Million)
24. Global Oral Vaccine Market share, by Research Institutes, By End User, 2015 - 2027 (USD Million)
25. Global Oral Vaccine Market share, by Others, By End User, 2015 - 2027 (USD Million)
26. Global Oral Vaccine Market share, by region, 2020 & 2027 (%)
27. Global Oral Vaccine Market share, by region, 2015 - 2027(USD Million)
28. North America Oral Vaccine Market , 2015 - 2027(USD Million)
29. North America Oral Vaccine Market share, by Countries, 2020 & 2027 (%)
30. U.S. Oral Vaccine Market , 2015 - 2027(USD Million)
31. Canada Oral Vaccine Market , 2015 - 2027(USD Million)
32. Mexico Oral Vaccine Market , 2015 - 2027(USD Million)
33. Europe Oral Vaccine Market , 2015 - 2027(USD Million)
34. Europe Oral Vaccine Market share, by Countries, 2020 & 2027 (%)
35. Spain Oral Vaccine Market , 2015 - 2027(USD Million)
36. UK Oral Vaccine Market , 2015 - 2027(USD Million)
37. Italy Oral Vaccine Market , 2015 - 2027(USD Million)
38. Germany Oral Vaccine Market , 2015 - 2027(USD Million)
39. France Oral Vaccine Market , 2015 - 2027(USD Million)
40. Rest of Europe Oral Vaccine Market , 2015 - 2027(USD Million)
41. Asia-Pacific Oral Vaccine Market , 2015 - 2027(USD Million)
42. Asia-Pacific Oral Vaccine Market share, by Countries, 2020 & 2027 (%)
43. China Oral Vaccine Market , 2015 - 2027(USD Million)
44. India Oral Vaccine Market , 2015 - 2027(USD Million)
45. Australia Oral Vaccine Market , 2015 - 2027(USD Million)
46. Japan Oral Vaccine Market , 2015 - 2027(USD Million)
47. Rest of Asia-Pacific Oral Vaccine Market , 2015 - 2027(USD Million)
48. Middle East & Africa Oral Vaccine Market , 2015 - 2027(USD Million)
49. Middle East & Africa Oral Vaccine Market share, by Countries, 2020 & 2027 (%)
50. GCC Oral Vaccine Market , 2015 - 2027(USD Million)
51. South Africa Oral Vaccine Market , 2015 - 2027(USD Million)
52. Rest Of Middle East & Africa Oral Vaccine Market , 2015 - 2027(USD Million)
53. South America Oral Vaccine Market , 2015 - 2027(USD Million)
54. Brazil Oral Vaccine Market , 2015 - 2027(USD Million)
55. Mexico Oral Vaccine Market , 2015 - 2027(USD Million)
56. Argentina Oral Vaccine Market , 2015 - 2027(USD Million)
57. Rest Of South America Oral Vaccine Market , 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Oral Vaccine Market , 2015-2027(USD Million)
4. Lactase requirement, by country, 2015-2027, (USD Million)
5. North America Oral Vaccine Market , By Vaccine Type, 2015-2027(USD Million)
6. North America Oral Vaccine Market , By Application, 2015-2027(USD Million)
7. North America Oral Vaccine Market , By End User, 2015-2027(USD Million)
8. Europe Oral Vaccine Market , By Vaccine Type, 2015-2027(USD Million)
9. Europe Oral Vaccine Market , By Application, 2015-2027(USD Million)
10. Europe Oral Vaccine Market , By End User, 2015-2027(USD Million)
11. Asia Pacific Oral Vaccine Market , By Vaccine Type, 2015-2027(USD Million)
12. Asia Pacific Oral Vaccine Market , By Application, 2015-2027(USD Million)
13. Asia Pacific Oral Vaccine Market , By End User, 2015-2027(USD Million)
14. Middle East & Africa Oral Vaccine Market , By Vaccine Type, 2015-2027(USD Million)
15. Middle East & Africa Oral Vaccine Market , By Application, 2015-2027(USD Million)
16. Middle East & Africa Oral Vaccine Market , By End User, 2015-2027(USD Million)
17. South America Oral Vaccine Market , By Vaccine Type, 2015-2027(USD Million)
18. South America Oral Vaccine Market , By Application, 2015-2027(USD Million)
19. South America Oral Vaccine Market , By End User, 2015-2027(USD Million)
20. Global Oral Vaccine Market, Company Market Share, 2020 - 2027 (%)
21. GlaxoSmithKline Plc: Product Benchmarking
22. GlaxoSmithKline Plc: Financial Performance
23. Merck & Co. Inc: Product Benchmarking
24. Merck & Co. Inc: Financial Performance
25. The Toro Company: Product Benchmarking
26. The Toro Company: Financial Performance
27. Aventis : Product Benchmarking
28. Aventis : Financial Performance
29. Swiss Serum and Vaccine Institute Berne: Product Benchmarking
30. Swiss Serum and Vaccine Institute Berne: Financial Performance
31. PaxVax Corporation: Product Benchmarking
32. PaxVax Corporation: Financial Performance
33. VALNEVA Canada Inc: Product Benchmarking
34. VALNEVA Canada Inc: Financial Performance
35. Janssen Pharmaceuticals.: Product Benchmarking
36. Janssen Pharmaceuticals.: Financial Performance
The Leading Key Players in Oral Vaccine Market
